Scott Gottlieb

Schweiger Dermatology Group (United States)

MedicineEconomics, Econometrics and FinancePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)”.

A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)

Journal of Investigative Dermatology(2020)10.1016/j.jid.2020.01.025

N/A

3.0DataRank · unranked

96 citations

Daniel B. Shin, Kristina Callis Duffin, April Armstrong, Andrew Blauvelt, Stephen K. Tyring +16 more

Securing America’s Pharmaceutical Innovation Edge

JAMA Health Forum(2025)10.1001/jamahealthforum.2025.4592

N/A

0DataRank · unranked

1 citations

Scott Gottlieb